Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity

[1]  John T. Chang,et al.  Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA-seq , 2017, Nature Immunology.

[2]  Qiang Yu,et al.  EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma. , 2016, Blood.

[3]  Christian S. Hinrichs,et al.  Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy , 2016, Clinical Cancer Research.

[4]  F. Marincola,et al.  Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. , 2015, The Journal of clinical investigation.

[5]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[6]  Mark S. Sundrud,et al.  Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. , 2015, Cancer research.

[7]  M. Kester,et al.  Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. , 2014, Blood.

[8]  T. Speed,et al.  Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. , 2014, Immunity.

[9]  John T. Chang,et al.  Molecular regulation of effector and memory T cell differentiation , 2014, Nature Immunology.

[10]  Ya-jun Guo,et al.  Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice , 2014, The Journal of Immunology.

[11]  H. Heslop,et al.  Antiviral T‐cell therapy , 2014, Immunological reviews.

[12]  C. June,et al.  Engineering T cells for cancer: our synthetic future , 2014, Immunological reviews.

[13]  N. Restifo,et al.  Uncoupling T‐cell expansion from effector differentiation in cell‐based immunotherapy , 2014, Immunological reviews.

[14]  S. Riddell,et al.  Design and implementation of adoptive therapy with chimeric antigen receptor‐modified T cells , 2014, Immunological reviews.

[15]  N. Restifo,et al.  Lineage relationship of effector and memory T cells. , 2013, Current opinion in immunology.

[16]  G. Alexe,et al.  Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions. , 2013, Immunity.

[17]  D. Nam,et al.  Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. , 2013, Cancer cell.

[18]  Joost B. Beltman,et al.  Heterogeneous Differentiation Patterns of Individual CD8+ T Cells , 2013, Science.

[19]  Thomas Höfer,et al.  Disparate Individual Fates Compose Robust CD8+ T Cell Immunity , 2013, Science.

[20]  T. Speed,et al.  Id2-Mediated Inhibition of E2A Represses Memory CD8+ T Cell Differentiation , 2013, The Journal of Immunology.

[21]  G. Belz,et al.  Role of PI3K/Akt signaling in memory CD8 T cell differentiation , 2013, Front. Immun..

[22]  M. Loda,et al.  EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent , 2012, Science.

[23]  Burton E. Barnett,et al.  Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection , 2012, Science.

[24]  Susan M. Kaech,et al.  Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.

[25]  C. Klebanoff,et al.  Paths to stemness: building the ultimate antitumour T cell , 2012, Nature Reviews Cancer.

[26]  F. Bushman,et al.  Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells , 2012, Science Translational Medicine.

[27]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[28]  E. Yang,et al.  The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets , 2011, Nature Immunology.

[29]  F. Marincola,et al.  Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits CD8+ T cell memory formation , 2011, Nature Immunology.

[30]  Qiang Yu,et al.  Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. , 2011, Molecular cell.

[31]  F. Marincola,et al.  A human memory T-cell subset with stem cell-like properties , 2011, Nature Medicine.

[32]  I. V. Alekseeva,et al.  [Development of acute myeloid leukemia from donor cells after allogeneic peripheral blood stem cell transplantation in a female patient with acute monoblastic leukemia]. , 2011, Terapevticheskii arkhiv.

[33]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[34]  B. Kee,et al.  SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics. , 2010, Immunity.

[35]  Nigel M de S Cameron,et al.  Our synthetic future , 2009, Nature Biotechnology.

[36]  W. Pear,et al.  Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. , 2009, Blood.

[37]  M. Sadelain.  T-cell engineering for cancer immunotherapy. , 2009, Cancer journal.

[38]  C. Mackall,et al.  Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts. , 2009, Blood.

[39]  Michael J. Bevan,et al.  The precursors of memory: models and controversies , 2009, Nature Reviews Immunology.

[40]  Dustin E. Schones,et al.  Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. , 2009, Immunity.

[41]  P. Muranski,et al.  Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells , 2009, Nature Medicine.

[42]  G. Crabtree,et al.  Understanding the Words of Chromatin Regulation , 2009, Cell.

[43]  Yuka Kanno,et al.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.

[44]  E. Wherry,et al.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection. , 2007, Immunity.

[45]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[46]  John T. Chang,et al.  Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses , 2007, Science.

[47]  M. Bevan,et al.  Effector and memory CTL differentiation. , 2007, Annual review of immunology.

[48]  Kristian Helin,et al.  The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. , 2007, Genes & development.

[49]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[50]  R. Paro,et al.  Polycomb/Trithorax response elements and epigenetic memory of cell identity , 2007, Development.

[51]  Ming You,et al.  TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.

[52]  M. Bevan,et al.  Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response , 2006, The Journal of experimental medicine.

[53]  J. Zeitlinger,et al.  Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.

[54]  Jiang Zhu,et al.  Host-reactive CD8+ memory stem cells in graft-versus-host disease , 2005, Nature Medicine.

[55]  M. Hung,et al.  Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3 , 2005, Science.

[56]  M. Bevan,et al.  Shortening the Infectious Period Does Not Alter Expansion of CD8 T Cells but Diminishes Their Capacity to Differentiate into Memory Cells1 , 2004, The Journal of Immunology.

[57]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[58]  Hao Shen,et al.  Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin , 2003, Science.

[59]  S. Rosenberg,et al.  Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells , 2003, The Journal of experimental medicine.

[60]  B. Chait,et al.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement , 2003, Nature Immunology.

[61]  Jiang Zhu,et al.  APCs in the Liver and Spleen Recruit Activated Allogeneic CD8+ T Cells to Elicit Hepatic Graft-Versus-Host Disease1 , 2002, The Journal of Immunology.

[62]  Steffen Jung,et al.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.

[63]  J. Harty,et al.  Programmed contraction of CD8+ T cells after infection , 2002, Nature Immunology.

[64]  Jiang Zhu,et al.  Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. , 2002, The Journal of clinical investigation.

[65]  Eric G. Pamer,et al.  Early Programming of T Cell Populations Responding to Bacterial Infection1 , 2000, The Journal of Immunology.

[66]  John T. Chang,et al.  Early transcriptional and epigenetic regulation of CD 8 + T cell differentiation revealed by single-cell RNA sequencing , 2017 .

[67]  T. Speed,et al.  Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8 T Cell Differentiation , 2014 .

[68]  S. Varambally,et al.  Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. , 2012, Blood.

[69]  D. Fearon.  The expansion and maintenance of antigen-selected CD8(+) T cell clones. , 2007, Advances in immunology.

[70]  Susan M. Kaech,et al.  Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .